IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Chris Wilkinson who wrote (98)	9/4/1997 7:38:00 PM
From: Logain Ablar	of 1510

Chris: Phase III just began in May / June time frame. Scheduled to go over 2 years BUT the speculation and hope is that the first mark (data compilation point) in November will indicate that the results are so strongly positive that it would be inhumane to continue the trails. Means that its inhumane to continue to give a plecabo to a percentage of the trial participants and inhumane to continue trial for 2 plus years and not have the drug on street to help inflicted. FDA grants this rarely, but with AIDs and the outcry all of the other "coctail" drugs have been granted the rapid approval. Once trials are halted it will still be a 2 to 3 months before FDA approval but the news of the trial halt will propell the stock. Still speculative but there were good phase i & ii results. Still may be some pull back but I can't see it below 8. (I'm neutral since I didn't mark my calendar until mid September to start to focus on this). I'm in LGND and will play this one out before IMNR. Good investing, Tim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next